Explore

Iterate

Vision

Gelesis

Gelesis is developing biomimetic superabsorbent hydrogel therapies for obesity and other chronic metabolic diseases.

Industries

Biotechnology

Headquarters

Boston, United States

Stage

Post IPO Equity

Employees

11-50

Links

Org chart

Yishai Zohar
CEO & Founder
Collapse
David Pass
Chief Operating & Commercial Officer
Elaine Chiquette
Chief Scientific Officer
Elliot Maltz
Chief Financial Officer
Joy Bauer
Chief Nutrition Officer of Plenity
Alessandro Sannino
Co-Inventor & Lead Project Scientist

Teams

View all

+10

Board of Directors

13 members

+3

Leadership Team

6 members

+2

CEO and Executive Team

5 members

Founding Team

1 members

Discover similar companies

Akoya Biosciences logo

Akoya Biosciences

Series D • San Francisco, United States

BioMarin Pharmaceutical logo

BioMarin Pharmaceutical

Post IPO Debt • San Rafael, United States

Exicure logo

Exicure

Post IPO Equity • Skokie, United States

BioAge logo

BioAge

Series C • Richmond, United States

Enko logo

Enko

Series C • Stonington, United States

Verve Therapeutics logo

Verve Therapeutics

Series B • Cambridge, United States

Biogen logo

Biogen

Cambridge, United States

Leapcure logo

Leapcure

Seed • Los Angeles, United States

Mission Bio logo

Mission Bio

Series C • San Francisco, United States

Genentech logo

Genentech

Venture • South San Francisco, United States

Vir Biotechnology logo

Vir Biotechnology

Post IPO Equity • San Francisco, United States

KBI Biopharma logo

KBI Biopharma

Venture • Durham, United States

Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.

Resources

About The OrgSupportCompaniesPeopleTeams

Solutions

Vision - Lead GenPartner with usHubSpot CRM Integration

Iterate

Employer BrandingJob TitlesTalent AcquisitionInterview QuestionsOrganizational StructureOnboardingPeople AnalyticsEmployee Engagement & RetentionNews

Visit us at

The OrgFacebookTwitter
© 2023 Orgio, Inc.
TermsPrivacyData